Biolife Solutions 

$22.33
14
+$0.53+2.43% Monday 21:00

Statistics

Day High
22.72
Day Low
21.79
52W High
29.62
52W Low
19.1
Volume
366,723
Avg. Volume
340,147
Mkt Cap
1.08B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.33
-0.22
-0.1
0.01
Expected EPS
-0.011967
Actual EPS
N/A

Financials

-16.82%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
239.98MRevenue
-40.37MNet Income

Analyst Ratings

$32.00Average Price Target
The highest estimate is 32.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BLFS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Brown & Brown
BRO
Mkt Cap27.22B
Brooks Automation provides automated cold storage solutions and services, competing in the biostorage sector with BioLife.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a broad range of products for the bioprocessing and preservation sectors, overlapping with BioLife's offerings.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company offers products and services in the biosciences field, including cell therapy solutions that compete with BioLife's products.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation's life sciences division offers products and services that compete in the bioprocessing and preservation space.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen provides sample and assay technologies for molecular diagnostics, applying preservation technologies that can compete with BioLife's solutions.
Illumina
ILMN
Mkt Cap18.99B
Illumina offers genomic sequencing solutions that require high-quality preservation of samples, indirectly competing with BioLife's preservation media.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences provides genomic analysis systems that also necessitate high-quality sample preservation, competing in the broader biopreservation market.
Agenus
AGEN
Mkt Cap126.5M
Agenus is involved in the discovery and development of immunotherapies, which requires the preservation of biological samples, indirectly competing with BioLife.
Novavax
NVAX
Mkt Cap1.36B
Novavax, a vaccine development company, requires stringent biopreservation for its products, making it a competitor in the biopreservation market.

About

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Show more...
CEO
Mr. Roderick de Greef
Employees
159
Country
US
ISIN
US09062W2044

Listings

0 Comments

Share your thoughts

FAQ

What is Biolife Solutions stock price today?
The current price of BLFS is $22.33 USD — it has increased by +2.43% in the past 24 hours. Watch Biolife Solutions stock price performance more closely on the chart.
What is Biolife Solutions stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biolife Solutions stocks are traded under the ticker BLFS.
Is Biolife Solutions stock price growing?
BLFS stock has fallen by -10.61% compared to the previous week, the month change is a -6.53% fall, over the last year Biolife Solutions has showed a -16.12% decrease.
What is Biolife Solutions market cap?
Today Biolife Solutions has the market capitalization of 1.08B
When is the next Biolife Solutions earnings date?
Biolife Solutions is going to release the next earnings report on March 12, 2026.
What were Biolife Solutions earnings last quarter?
BLFS earnings for the last quarter are 0.01 USD per share, whereas the estimation was -0.01 USD resulting in a +186.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biolife Solutions revenue for the last year?
Biolife Solutions revenue for the last year amounts to 239.98M USD.
What is Biolife Solutions net income for the last year?
BLFS net income for the last year is -40.37M USD.
How many employees does Biolife Solutions have?
As of February 03, 2026, the company has 159 employees.
In which sector is Biolife Solutions located?
Biolife Solutions operates in the Health Care sector.
When did Biolife Solutions complete a stock split?
The last stock split for Biolife Solutions was on January 29, 2014 with a ratio of 1:14.
Where is Biolife Solutions headquartered?
Biolife Solutions is headquartered in Bothell, US.